| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medical Biophysics, University of Toronto, and The Ontario Cancer Institute, Toronto, Ontario, Canada
L cells in the exponential growth phase in cell culture were exposed to vinblastine sulfate (VLB)3 for various lengths of time and tested for their ability to form macroscopic colonies and to progress through the phases of the cell-division cycle. Concentrations of VLB in the vicinity of 10-7 gm/ml were found to inhibit the proliferation of L cells and to cause an accumulation of mitotic figures, which reached a maximum after approximately 1 doubling time. The cells in the VLB-treated cultures showed a progressive loss of colony-forming ability; this loss was closely correlated with the accumulation of mitotic figures. When cells were prevented from entering mitosis by the action of a reversible inhibitor of cell proliferation, phenethyl alcohol, they showed no such progressive loss of colony-forming ability in the presence of VLB. Partially synchronized cell populations, in which only cells in late G1 phase retained colony-forming ability, were tested for their response to VLB. It was found that no loss of colony-forming ability occurred until the cells began to attempt cell division in the presence of VLB. Studies of the time relationships between the various phases of the cycle in VLB-treated cells did not reveal any important retarding effects of VLB on the progress of L cells through the phases of the cell cycle other than mitosis. VLB appears to act primarily on cells at or near mitosis and to cause an irreversible loss of colony-forming ability.
1 This investigation was supported in part by grants from the National Cancer Institute of Canada, and the USPHS (grant CA-06229-02).
3 The abbreviations used are: VLB, vinblastine sulfate; Tdr-3H, tritiated thymidine; DNA, deoxyribonucleic acid; PEA, phenethyl alcohol; S, DNA synthesis period; G1, pre-S period; G2, post-S period; and M, mitosis.
2 Research Fellow of the National Cancer Institute of Canada.
Received 3/10/65.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |